Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Completed · Phase 4

Conditions studied: Anemia, Iron-Deficiency, Kidney Failure, Chronic

In brief

This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease patients who are receiving erythropoietic agents, such as Procrit® and Aranesp®.

Key facts

Study ID

NCT00224042

Run by

Watson Pharmaceuticals

People needed

52

Starts

2003-04-01

Last updated by the study team

2012-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate to severe anemia
• Iron deficiency
• Moderate to severe chronic kidney disease
• Receiving therapy with erythropoietic agent

You may not qualify if…

• Receiving dialysis
• Known sensitivity to Ferrlecit® or any of its components
• Clinically unstable

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Tucson, Arizona, United States
• Study site — Los Angeles, California, United States
• Study site — Palo Alto, California, United States
• Study site — San Diego, California, United States
• Study site — Hines, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Baltimore, Maryland, United States
• Study site — Springfield, Massachusetts, United States
• Study site — St Louis, Missouri, United States
• Study site — Detroit, New York, United States
• Study site — Mineola, New York, United States
• Study site — New York, New York, United States
• Study site — The Bronx, New York, United States
• Study site — Chapel Hill, North Carolina, United States
• Study site — Cleveland, Ohio, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Charlotte, South Carolina, United States
• Study site — Chattanooga, Tennessee, United States
• Study site — Memphis, Tennessee, United States
• Study site — Houston, Texas, United States
• Study site — Fairfax, Virginia, United States
• Study site — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.